Literature DB >> 3131178

Cure of hemophilia A by orthotopic liver transplantation.

A Gibas1, J L Dienstag, A I Schafer, F Delmonico, T E Bynum, R Schooley, R H Rubin, A B Cosimi.   

Abstract

A patient with hemophilia A and transfusion-associated end-stage chronic liver disease underwent orthotopic liver transplantation. He had no requirement for exogenous factor VIII replacement during the 27 mo he survived. Although his hemophilia was cured, he had antibodies to the human immunodeficiency virus; ultimately he died of complications arising from acquired immunodeficiency syndrome. Liver transplantation for cirrhotic hemophiliacs can free them of the need for antihemophilic-factor therapy; however, application of this approach may be limited by the high prevalence of human immunodeficiency virus infection in multitransfused hemophiliacs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131178     DOI: 10.1016/0016-5085(88)90310-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Liver transplantation for haemophiliacs with hepatitis C cirrhosis.

Authors:  M McCarthy; E Gane; S Pereira; C J Tibbs; N Heaton; M Rela; H Hambley; R Williams
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Hope for haemophilic patients with hepatitis.

Authors:  C A Lee
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  Outcome of orthotopic liver transplantation in patients with haemophilia.

Authors:  F H Gordon; P K Mistry; C A Sabin; C A Lee
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

4.  Donor-to-recipient transmission of factor XII deficiency by orthotopic liver transplantation.

Authors:  Hussien Elsiesy; Mohamed Shawakat; Waleed Alhamoudi; Mohamed Alsebayel; John Renz; Hany Elbeshbeshy; Mohamed Abdelfattah; Faisal Abaalkhail
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-19

5.  Orthotopic liver transplantation for hepatitis C infection: the best Christmas present?

Authors:  S D Johnston; O McNulty; E Mayne; M E Callender
Journal:  Ulster Med J       Date:  1998-11

6.  Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX.

Authors:  Suvasini Ramaswamy; Nina Tonnu; Tushar Menon; Benjamin M Lewis; Kevin T Green; Derek Wampler; Paul E Monahan; Inder M Verma
Journal:  Cell Rep       Date:  2018-05-01       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.